Systemic polyarteritis nodosa following hepatitis B vaccination

European Journal of Internal Medicine

Volumn 19, Issue 8, 2008, Pages 575-578

  Carvalho, Jozélio Freire de ^a,b   Pereira, Rosa Maria Rodrigues ^a   Shoenfeld, Yehuda ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Hepatitis B; Hepatitis B vaccination; Polyarteritis nodosa; Vaccination; Vaccine; Vasculitis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; AUTOIMMUNITY; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEVER; GENETIC PREDISPOSITION; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMUNOPATHOGENESIS; LIVEDO RETICULARIS; MALE; MOLECULAR MIMICRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; POLYARTERITIS NODOSA; REVIEW; SCROTAL PAIN; VASCULITIS; WEIGHT REDUCTION;

ADOLESCENT; ADRENAL CORTEX HORMONES; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HEPATITIS B VACCINES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; POLYARTERITIS NODOSA; TREATMENT OUTCOME;

EID: 56949106820     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.06.035     Document Type: Review

References (57)

1. Chen R.T., Pless R., and Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 16 (2001) 309-318
2. Guillevin L., Lhote F., Cohen P., Sauvaget F., Jarrousse B., Lortholary O., et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 74 (1995) 238-253
3. Bourgeais A.M., Dore M.X., Croue A., Leclech C., and Verret J.L. [Cutaneous polyarteritis nodosa following hepatitis B vaccination]. Ann Dermatol Venereol 130 (2003) 205-207
4. Saadoun D., Cacoub P., Mahoux D., Sbai A., and Piette J.C. Postvaccine vasculitis: a report of three cases]. Rev Med Interne 22 (2001) 172-176
5. De Keyser F., Naeyaert J.M., Hindryckx P., Elewaut D., Verplancke P., Peene I., et al. Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol 18 (2000) 81-85
6. Bouroz-Joly J., Hachulla E., Vermersch P., Pruvo J.P., Hatron P.Y., and Devulder B. [Between the infection and the vaccine, one must choose]. Rev Med Interne 19 Suppl 2 (1998) 286s-289s
7. Kerleau J.M., Levesque H., Lair G., Lecomte F., Carrara O., and Courtois H. [Is hepatitis B vaccination a new cause of necrotizing vasculitis?]. Rev Med Interne 18 (1997) 491-492
8. Le Goff P., Fauquert P., Youinou P., and Hoang S. [Periarteritis nodosa following vaccination against hepatitis B]. Presse Med 17 (1988) 1763
9. Zhou W., Pool V., Iskander J.K., English-Bullard R., Ball R., Wise R.P., et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. MMWR Surveill Summ 52 (2003) 1-24
10. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 40 (1991) 1-25
11. Aharon-Maor A., and Shoenfeld Y. The good, the bad and the ugly of vaccination. Isr Med Assoc J 2 (2000) 225-227
12. Shoenfeld Y., and Isenberg D.A. The mosaic of autoimmunity. Immunol Today 10 (1989) 123-126
13. Tishler M., and Shoenfeld Y. Vaccination may be associated with autoimmune diseases. Isr Med Assoc J 6 (2004) 430-432
14. Fujinami R.S., and Oldstone M.B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230 (1985) 1043-1045
15. Shoenfeld Y., Aharon-Maor A., and Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol 18 (2000) 181-184
16. Shoenfeld Y., and Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?. J Autoimmun 14 (2000) 1-10
17. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13 (2000) 470-511
18. Brickman C.M., and Shoenfeld Y. The mosaic of autoimmunity. Scand J Clin Lab Invest Suppl 235 (2001) 3-15
19. Tudela P., Marti S., and Bonal J. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron 62 (1992) 236
20. Finielz P., Lam-Kam-Sang L.F., and Guiserix J. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrol Dial Transplant 13 (1998) 2420-2421
21. Guiserix J. Systemic lupus erythematosus following hepatitis B vaccine. Nephron 74 (1996) 4.41
22. Mamoux V., and Dumont C. [Lupus erythematosus disseminatus and vaccination against hepatitis B virus]. Arch Pediatr 1 (1994) 307-308
23. Grezard P., Chefai M., Philippot V., Perrot H., and Faisant M. [Cutaneous lupus erythematosus and buccal aphthosis after hepatitis B vaccination in a 6-year-old child]. Ann Dermatol Venereol 123 (1996) 657-659
24. O'Neill S.G., and Isenberg D.A. Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety. Lupus 15 (2006) 778-783
25. Le Hello C., Cohen P., Bousser M.G., Letellier P., and Guillevin L. Suspected hepatitis B vaccination related vasculitis. J Rheumatol 26 (1999) 191-194
26. Carmeli Y., and De-Medina T. Serious hepatitis B vaccine adverse reactions, are they immune-mediated?. Vaccine 11 (1993) 1358-1359
27. Begier E.M., Langford C.A., Sneller M.C., Wise R.P., and Ball R. Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccineprovoked vasculitis. J Rheumatol 31 (2004) 2181-2188
28. Mader R., Narendran A., Lewtas J., Bykerk V., Goodman R.C., Dickson J.R., et al. Systemic vasculitis following influenza vaccination-report of 3 cases and literature review. J Rheumatol 20 (1993) 1429-1431
29. Reveille J.D., Goodman R.E., Barger B.O., and Acton R.T. Familial polyarteritis nodosa: a serologic and immunogenetic analysis. J Rheumatol 16 (1989) 181-185
30. Carmeli Y., and Oren R. Hepatitis B vaccine side-effect. Lancet 341 (1993) 250-251
31. Bentsi-Enchill A. Adverse events following the administration of hepatitis B vaccines. Can Commun Dis Rep 18 (1992) 49-53
32. Aron-Maor A., and Shoenfeld Y. BCG immunisation and the 'Trojan horse' phenomenon of vaccination. Clin Rheumatol 22 (2003) 6-7
33. Calista D., and Morri M. Lichen planus induced by hepatitis B vaccination: a new case and review of the literature. Int J Dermatol 43 (2004) 562-564
34. Al-Khenaizan S. Lichen planus occurring after hepatitis B vaccination: a new case. J Am Acad Dermatol 45 (2001) 614-615
35. Erbagci Z. Childhood bullous pemphigoid following hepatitis B immunization. J Dermatol 29 (2002) 781-785
36. Loche F., Schwarze H.P., Thedenat B., Carriere M., and Bazex J. Erythema multiforme associated with hepatitis B immunization. Clin Exp Dermatol 25 (2000) 167-168
37. Chave T., Neal C., and Camp R. Henoch-Schonlein purpura following hepatitis B vaccination. J Derm Treat 14 (2003) 179-181
38. Andiran N., Senturk G.B., and Bukulmez G. Combined vaccination by measles and hepatitis B vaccines: a new cause of Gianotti-Crosti syndrome. Dermatology 204 (2002) 75-76
39. Aron-Maor A., and Shoenfeld Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus 10 (2001) 237-240
40. Maillefert J.F., Sibilia J., Toussirot E., Vignon E., Eschard J.P., Lorcerie B., et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) 38 (1999) 978-983
41. Pope J.E., Stevens A., Howson W., and Bell D.A. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 25 (1998) 1687-1693
42. Nuevo H., Nascimento-Carvalho C.M., Athayde-Oliveira C.P., Lyra I., and Moreira L.M. Thrombocytopenic purpura after hepatitis B vaccine: case report and review of the literature. Pediatr Infect Dis J 23 (2004) 183-184
43. Meyboom R.H., Fucik H., and Edwards I.R. Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet (1995) 345: 1638
44. Viallard J.F., Boiron J.M., Parrens M., Moreau J.F., Ranchin V., Reiffers J., et al. Severe pancytopenia triggered by recombinant hepatitis B vaccine. Br J Haematol 110 (2000) 230-233
45. Chen R.T., Pless R., and Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 16 (2001) 309-318
46. Confavreux C., Suissa S., Saddier P., Bourdes V., and Vukusic S. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med 344 (2001) 319-326
47. Ascherio A., Zhang S.M., Hernan M.A., Olek M.J., Coplan P.M., Brodovicz K., et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 344 (2001) 327-332
48. Karaali-Savrun F., Altintas A., Saip S., and Siva A. Hepatitis B vaccine related-myelitis?. Eur J Neurol 8 (2001) 711-715
49. Creange A., Temam G., and Lefaucheur J.P. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity 30 (1999) 143-146
50. Khamaisi M., Shoenfeld Y., and Orbach H. Guillain-Barre syndrome following hepatitis B vaccination. Clin Exp Rheumatol 22 (2004) 767-770
51. Pennesi M., Torre G., Del Santo M., and Sonzogni A. Glomerulonephritis after recombinant hepatitis B vaccine. Pediatr Infect Dis J 21 (2002) 172-173
52. Rogerson S.J., and Nye F.J. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. BMJ 301 (1990) 345
53. Louzir B., Othmani S., Battikh R., Ben Abdelhafidh N., Bahri M., Taalouche L., et al. [Myasthenia after hepatitis B vaccination]. Therapie 58 (2003) 378-379
54. Fried M., Conen D., Conzelmann M., and Steinemann E. Uveitis after hepatitis B vaccination. Lancet 2 (1987) 631-632
55. Hassan W., and Oldham R. Reiter's syndrome and reactive arthritis in health care workers after vaccination. BMJ 309 (1994) 94
56. Rodriguez-Lopez J.N., Banon-Arnao M., Martinez-Ortiz F., Tudela J., Acosta M., Varon R., et al. Catalytic oxidation of 2,4,5-trihydroxyphenylalanine by tyrosinase: identification and evolution of intermediates. Biochim Biophys Acta 1160 (1992) 221-228
57. Lilic D., and Ghosh S.K. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet 344 (1994) 1292-1293